Table 1. Characteristics of the patients included in the study (N = 26).a .
| Variable | Result |
|---|---|
| Age, years | 9.5 (7.0-11.0) |
| Male/female gender, n/n | 19/7 |
| BMI, kg/m2 | 20 ± 4 |
| Allergic rhinitis | < 100% |
| Secondhand smoke | < 38% |
| Uncontrolled asthma | < 35% |
| Daily dose of inhaled corticosteroid, µg | 400 (200-400) |
| Vitamin D, ng/mL | 24 (19-31) |
| Total IgE, IU/mL | 706 (515-1,583) |
| Eosinophils, % | 9.5 ± 6.7 |
| Eosinophils, cells/µL | 653 ± 471 |
| FEV1, % predicted | 90 ± 9 |
| Post-BD FEV1, % predicted | 105 ± 14 |
| FEV1/FVC | 78 ± 7 |
| FEV1/FVC post-BD | 84 ± 3 |
| FEF25-75%, % predicted | 96 ± 23 |
| Post-BD FEF25-75%, % predicted | 136 ± 36 |
BD: bronchodilator. aValues expressed as mean ± SD or median (interquartile interval), except where otherwise indicated.